Ann Aine Hanly

2021

In 2021, Ann Aine Hanly earned a total compensation of $4.7M as Chief Technology Officer at Vir Biotechnology.

Compensation breakdown

Bonus$250,000
Non-Equity Incentive Plan$249,200
Option Awards$2,367,738
Salary$338,385
Stock Awards$1,451,400
Other$84,635
Total$4,741,358

Hanly received $2.4M in option awards, accounting for 50% of the total pay in 2021.

Hanly also received $250K in bonus, $249.2K in non-equity incentive plan, $338.4K in salary, $1.5M in stock awards and $84.6K in other compensation.

Rankings

In 2021, Ann Aine Hanly's compensation ranked 2,780th out of 12,415 executives tracked by ExecPay. In other words, Hanly earned more than 77.6% of executives.

ClassificationRankingPercentile
All
2,780
out of 12,415
78th
Division
Manufacturing
1,101
out of 5,505
80th
Major group
Chemicals And Allied Products
435
out of 2,375
82nd
Industry group
Drugs
379
out of 2,096
82nd
Industry
Biological Products, Except Diagnostic Substances
109
out of 449
76th
Source: SEC filing on April 7, 2022.

Hanly's colleagues

We found four more compensation records of executives who worked with Ann Aine Hanly at Vir Biotechnology in 2021.

2021

George Scangos

Vir Biotechnology

Chief Executive Officer

2021

Phillip Pang

Vir Biotechnology

Chief Medical Officer

2021

Herbert Virgin

Vir Biotechnology

Chief Scientific Officer

2021

Howard Horn

Vir Biotechnology

Chief Financial Officer

News

You may also like